iBio, Inc.

iBio, Inc.verified

IBIO

Price:

$2.64

Market Cap:

$24.15M

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing re...[Read more]

Industry

Biotechnology

IPO Date

2008-08-19

Stock Exchange

AMEX

Ticker

IBIO

The Enterprise Value as of November 2024 (TTM) for iBio, Inc. (IBIO) is 17.35M

According to iBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.35M. This represents a change of 16.20% compared to the average of 14.93M of the last 4 quarters.

iBio, Inc. (IBIO) Historical Enterprise Value (quarterly & annually)

How has IBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of iBio, Inc. over the last ten years is 410.71M. The current 17.35M Enterprise Value has changed 322.43% with respect to the historical average. Over the past ten years (40 quarters), IBIO's Enterprise Value was at its highest in in the June 2015 quarter at 1.44B. The Enterprise Value was at its lowest in in the June 2024 quarter at 7.58M.

Quarterly (TTM)
Annual

Average

410.71M

Median

219.52M

Minimum

-2049690.00

Maximum

1.35B

iBio, Inc. (IBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of iBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 156.77%

Maximum Annual Enterprise Value = 1.35B

Minimum Annual Increase = -110.13%

Minimum Annual Enterprise Value = -2049690.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-2049690.00-110.13%
202320.24M-67.25%
202261.80M-75.35%
2021250.71M5.11%
2020238.53M121.27%
2019107.80M-46.24%
2018200.50M-71.85%
2017712.24M-39.04%
20161.17B-13.38%
20151.35B156.77%

iBio, Inc. (IBIO) Average Enterprise Value

How has IBIO Enterprise Value performed in the past?

The current Enterprise Value of iBio, Inc. (IBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.67M

5-year avg

113.85M

10-year avg

410.71M

iBio, Inc. (IBIO) Enterprise Value vs. Peers

How is IBIO’s Enterprise Value compared to its peers?

iBio, Inc.’s Enterprise Value is less than Jaguar Health, Inc. (33.27M), greater than Onconova Therapeutics, Inc. (4.51M), less than GeoVax Labs, Inc. (19.24M), less than Ocugen, Inc. (232.43M), greater than Tonix Pharmaceuticals Holding Corp. (15.97M), greater than Acasti Pharma Inc. (14.78M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-907921.00), greater than Palisade Bio, Inc. (-4438971.00), less than Vaxart, Inc. (0), less than ADMA Biologics, Inc. (132.65M), less than BioCryst Pharmaceuticals, Inc. (5.03B), less than null (2.29B),

Build a custom stock screener for iBio, Inc. (IBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iBio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iBio, Inc. (IBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is iBio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for iBio, Inc. (IBIO)?

What is the 3-year average Enterprise Value for iBio, Inc. (IBIO)?

What is the 5-year average Enterprise Value for iBio, Inc. (IBIO)?

How does the current Enterprise Value for iBio, Inc. (IBIO) compare to its historical average?